Table 2.
Antimicrobial susceptibility pattern of Gram-negative bacteria isolated from urine cultures obtained from pediatric patients
| BI | F | DS | AMP | CIP | CAF | CRO | GEN | NIT | SXT | TTC | CFP | PIC | TIC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No (%) | No (%) | No (%) | No (%) | No (%) | No (%) | No (%) | No (%) | ND | ND | ND | |||
| E. coli | 45 | S | 14 (31) | 37 (82) | 35 (78) | 34 (76) | 36 (80) | 40 (89) | 33 (73) | 25 (56) | ND | ND | ND |
| R | 31 (69) | 8 (18) | 10 (22) | 11 (24) | 9 (20) | 5 (11) | 12 (27) | 20 (44) | ND | ND | ND | ||
|
| |||||||||||||
| Citrobacter | 01 | S | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | ND | ND | ND |
| R | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (100) | 0 (100) | 0 (100 | ND | ND | ND | ||
|
| |||||||||||||
| Entrobacteraerogen | 04 | S | 2 (50) | 3 (75) | 3 (75) | 4 (100) | 2 (50) | 4 (100) | 3 (75) | 4 (100) | ND | ND | ND |
| R | 2 (50) | 1 (25) | 1 (25) | 0 (0) | 2 (50) | 0 (0) | 1 (25) | 0 (0) | ND | ND | ND | ||
|
| |||||||||||||
| P. vulgaris | 04 | S | 2 (50) | 3 (75) | 2 (50) | 4 (100) | 4 (100) | 3 () | 4 (100) | 2 (50) | ND | ND | ND |
| R | 2 (50) | 1 (25) | 2 (5) | 0 (0) | 0 (0) | 1 (25) | 0 (0) | 2 (50) | ND | ND | ND | ||
|
| |||||||||||||
| P. mirabils | 01 | S | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | ND | ND | ND |
| R | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | ND | ND | ND | ||
|
| |||||||||||||
| K.pneumoniae | 04 | S | 0 (0) | 2 (50) | 3 (75) | 4 (100) | 3 (75) | 4 (100) | 2 (50) | 1 (25) | ND | ND | ND |
| R | 4 (100) | 2 (50) | 1 (25) | 0 (0) | 1 (25) | 0 (0) | 2 (50) | 3 (75) | ND | ND | ND | ||
|
| |||||||||||||
| K.ozaenae | 01 | S | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | ND | ND | ND |
| R | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | ND | ND | ND | ||
|
| |||||||||||||
| P.aeruginosa | 08 | S | 1 (12.5) | 7 (87.5) | ND | ND | 8 (100) | 8 (100) | ND | ND | 7 (87.5) | 8(100) | 8(100) |
| R | 7 (87.5) | 1 (12.5) | ND | ND | 0 (0) | 0 (0) | ND | ND | 1 (12.5) | 0(0) | 0(0) | ||
|
| |||||||||||||
| Total | 68 | S | 19 (28) | 55 (80.88) | 45 (75) | 48 (80) | 54 (79.41) | 62 (91.18) | 43 (72) | 35 (58) | 7 (87.5) | 8(100) | 8(100) |
| R | 49 (72) | 13 (19.12) | 15 (25) | 12 (20) | 14 (20.59) | 6 (8.82) | 17 (28) | 25 (42) | 1 (12.5) | 0 (0) | 0 (0) | ||
AMP: ampicillin; CAF: chloramphenicol; NIT: nitrofurantoin; CIP: ciprofloxacin; SXT: co-trimoxazole; CRO: ceftriaxone; GN: gentamicin; TTC: tetracycline; TIC: ticracin; CFP: cefepiem; P: cefepime; PIC:pepracillin; ND: not done; F: frequency; BI: bacterial isolate; DS: drug sensitivity pattern; S: sensitivity; R:resistance